| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/03/1992 | WO1992012237A1 Fusions of a viral protein and a destructive enzyme |
| 07/01/1992 | EP0492920A1 Chimaeric influenza-HIV vaccine |
| 07/01/1992 | EP0491757A1 Process for inactivating viruses in blood and blood products |
| 06/30/1992 | US5126260 Gene therapy for genetic blood disorders |
| 06/25/1992 | WO1992010578A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2614365A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2098292A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | CA2057963A1 Chimaeric influenza-hiv vaccine |
| 06/24/1992 | EP0491125A1 Vaccines against equine herpes viruses and their preparation |
| 06/23/1992 | US5124263 Recombination resistant retroviral helper cell and products produced thereby |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/17/1992 | DE4040043A1 New acid-stable and infectious human rhinovirus mutant - prepd. by incubating wild type virus at varying pH, useful for treating rhinoviral infection |
| 06/16/1992 | CA1303525C Rotavirus reassortant vaccine |
| 06/16/1992 | CA1303500C Feline infectious peritonitis vaccine |
| 06/16/1992 | CA1303483C Microencapsulated insecticidal pathogens |
| 06/14/1992 | WO1992010564A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| 06/14/1992 | CA2098510A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| 06/09/1992 | US5120649 Photodynamic inactivation of viruses in blood cell-containing compositions |
| 06/03/1992 | EP0488528A1 Recombinant adeno-associated virus vectors |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/02/1992 | US5118602 Feline T-lymphotropic lentivirus assay |
| 05/29/1992 | WO1992008789A1 Measles virus recombinant poxvirus vaccine |
| 05/29/1992 | WO1992008787A1 Method of propagating human paramyxoviruses using continuous cell lines |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008784A1 Human t-lymphotropic virus type 2 from guaymi indians in panama |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486562A1 Mutant pseudorabies virus, and vaccines containing the same |
| 05/21/1992 | CA2096633A1 Measles virus recombinant poxvirus vaccine |
| 05/20/1992 | EP0486170A1 Baculoviral expression system comprising procaryotic leader sequence |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0485701A1 Insertion of DNA by modified transposons |
| 05/20/1992 | EP0485652A1 Process to prepare vaccines against pathologic agents |
| 05/19/1992 | US5115098 End-blocked peptides inhibiting binding capacity of gp120 |
| 05/17/1992 | WO1992008786A1 Human rotaviruses, vaccines and methods |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/14/1992 | WO1992007950A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2072581A1 Method of gene transfer using retrotransposons |
| 05/13/1992 | EP0484396A1 Avipox virus promoters |
| 05/12/1992 | US5112756 Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells |
| 05/12/1992 | US5112753 Method of identification and preparation of probes for pestiviruses, oligonucleotides and probes thus obtained and a method of detection of pestiviruses |
| 05/10/1992 | WO1992008793A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/10/1992 | CA2095635A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/07/1992 | WO1992007958A1 Test for virulent revertants in attenuated live vaccines |
| 05/07/1992 | CA2095428A1 Test for virulent revertants in attenuated live vaccines |
| 05/06/1992 | EP0483304A1 Method of inactivation of viral and bacterial blood contaminants |
| 05/05/1992 | US5110729 Method of producing peptides using baculovirus vectors in cultured cells |
| 04/30/1992 | WO1992007077A1 Engineered bacteriophages and vaccines containing them |
| 04/30/1992 | WO1992007036A1 Selenomerocyanine photosensitizers |
| 04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
| 04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
| 04/30/1992 | CA2093919A1 Hepatitis c virus antibody |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5108920 Retrovirus isolated from human lymphoma cell lines |
| 04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/25/1992 | CA2054069A1 Expression system |
| 04/22/1992 | CN1016315B Process for preparing hepatitis b antigenic compositions |
| 04/21/1992 | US5106619 Preparation of inactivated viral vaccines |
| 04/21/1992 | US5106616 Administration of acemannan |
| 04/16/1992 | WO1992006191A1 Proteinaceous anti-dental plaque agents |
| 04/15/1992 | EP0480109A1 Tube or spangle for the cryogenic conservation of biological samples like virus, and procedure for filling |
| 04/08/1992 | EP0478689A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1 MN? gp 120 |
| 04/08/1992 | EP0478556A1 Characterization of a replication competent human immunodeficiency type 2 proviral clone |
| 04/05/1992 | WO1992006181A1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions |
| 04/02/1992 | WO1992006180A1 Targeting viruses and cells for selective internalization by cells |
| 04/02/1992 | WO1992005263A1 Viral defective vaccine produced by transcomplementing cell line |
| 04/02/1992 | CA2092323A1 Targeting viruses and cells for selective internalization by cells |
| 04/01/1992 | EP0478333A1 Gene selective expression with vectors containing protector and suppressor viral sequences |
| 04/01/1992 | EP0324811B1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 03/31/1992 | CA1298221C Production of phage-associated lysin for diagnosis of streptococcal infection |
| 03/29/1992 | CA2052324A1 Insertion of dna by modified transposons |
| 03/29/1992 | CA2052023A1 Expression vector construction utilizing viral sequences for selective expression of useful substances |
| 03/25/1992 | EP0477056A1 Recombinant herpes viruses, vaccines comprising them, process for preparation and US 3 genes |
| 03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
| 03/25/1992 | EP0476130A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 03/22/1992 | WO1992005266A2 Packaging cells |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods |
| 03/18/1992 | WO1992005265A1 Recombinant baculoviral vectors using early promotors |
| 03/18/1992 | WO1992005264A1 Multiple promoter baculovirus expression system and defective particle production |
| 03/18/1992 | EP0474868A1 Method of producing core structure of retro virus and particle produced thereby |
| 03/18/1992 | EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
| 03/18/1992 | CA2091887A1 Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
| 03/10/1992 | US5094850 Deactivation of virus |
| 03/08/1992 | CA2050850A1 Recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process |
| 03/05/1992 | WO1992004031A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | WO1992003547A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE |
| 03/05/1992 | WO1992003545A1 Flavivirus recombinant poxvirus vaccine |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003160A1 Papua new guinea human t-lymphotropic virus |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | CA2072871A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | CA2066160A1 Marek's disease herpesvirus dna segment encoding glycoproteins, gd, gi and ge |
| 03/04/1992 | EP0473210A2 Recombinant Marek's disease virus |
| 03/03/1992 | US5093258 For expressing immunogenic proteins, poultry vaccines |
| 03/01/1992 | WO1992005760A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
| 03/01/1992 | CA2089761A1 Method and compositions for diagnosing and treating chronic fatique immunodysfunction syndrome |